Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

HER2-positive Breast Cancer × pegfilgrastim × 90 days × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 4 Breast Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Hodgkin Disease 2 Burkitt Lymphoma 2 Triple Negative Breast Neoplasms 1 Teratoma 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Pain 1 Osteosarcoma 1 Neoplasms 1 Medulloblastoma 1 Lymphoma 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1 Infiltrating Bladder Urothelial Carcinoma 1 Heart Failure 1 Glioma 1 Fallopian Tube Neoplasms 1 Desmoplastic Small Round Cell Tumor 1 Dendritic Cell Sarcoma, Interdigitating 1 Choriocarcinoma 1 Central Nervous System Neoplasms 1 Cardiotoxicity 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Embryonal 1

Interventions

pertuzumab 2 Trastuzumab 2 tucatinib 1 pyrotinib 1 Paclitaxel 1 Fluorodeoxyglucose F18 1 Docetaxel 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡